RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 81 filers reported holding RECRO PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $83,000 | -1.2% | 29,644 | 0.0% | 0.00% | – |
| Q4 2020 | $84,000 | +35.5% | 29,644 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -54.1% | 29,644 | 0.0% | 0.00% | – |
| Q2 2020 | $135,000 | -44.2% | 29,644 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $242,000 | -57.1% | 29,644 | -3.6% | 0.00% | 0.0% |
| Q4 2019 | $564,000 | +68.9% | 30,749 | +1.9% | 0.00% | 0.0% |
| Q3 2019 | $334,000 | +11.3% | 30,178 | +2.3% | 0.00% | 0.0% |
| Q2 2019 | $300,000 | +81.8% | 29,490 | +4.7% | 0.00% | – |
| Q1 2019 | $165,000 | -17.5% | 28,164 | 0.0% | 0.00% | – |
| Q4 2018 | $200,000 | +5.3% | 28,164 | +5.5% | 0.00% | – |
| Q3 2018 | $190,000 | +41.8% | 26,704 | 0.0% | 0.00% | – |
| Q2 2018 | $134,000 | -42.2% | 26,704 | +26.9% | 0.00% | – |
| Q1 2018 | $232,000 | +16.0% | 21,041 | -2.6% | 0.00% | – |
| Q4 2017 | $200,000 | -0.5% | 21,600 | -3.6% | 0.00% | – |
| Q3 2017 | $201,000 | +18.9% | 22,400 | -7.1% | 0.00% | – |
| Q2 2017 | $169,000 | – | 24,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |